We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. An overview on the relationship between residential radon and lung cancer: what we know and future research

    We aim to provide an overview of the research available on indoor radon and lung cancer, with a special focus on Spanish investigations. Early...

    Alberto Ruano-Ravina, Lucia Martin-Gisbert, ... Leonor Varela-Lema in Clinical and Translational Oncology
    Article Open access 23 August 2023
  2. Difficulties on the access to innovative targeted therapies for lung cancer in Spain

    Purpose

    Spanish Lung Cancer Group (SLCG) conducted a review to analyze the barriers to access to innovative targeted therapies for non-small cell lung...

    Virginia Calvo, Carlos Camps, ... Mariano Provencio in Clinical and Translational Oncology
    Article Open access 31 August 2023
  3. Novel Therapeutic Options for Small Cell Lung Cancer

    Purpose of Review

    The aim of this review is to focus on the recent advances in the molecular knowledge of small cell lung cancer (SCLC) and potential...

    Stefania Canova, Benedetta Trevisan, ... Diego Luigi Cortinovis in Current Oncology Reports
    Article Open access 23 October 2023
  4. Continuous positive airway pressure is unsafe for radiofrequency ablation of lung cancer under sedation: a randomised controlled trial

    Objective

    To evaluate the safety of a minimum continuous positive airway pressure of 4 cmH 2 O (CPAP + 4) during computed tomography (CT)-guided...

    Enrique Carrero-Cardenal, Ivan Vollmer-Torrubiano, ... Ricard Valero-Castell in Insights into Imaging
    Article Open access 20 June 2024
  5. Effect of Baduan** qigong on postoperative pulmonary rehabilitation in patients with non-small cell lung cancer: a randomized controlled trial

    Purpose

    The purpose of this study was to explore the effect of Baduan** qigong on improving lung function and postoperative quality of life of...

    Jilai Xu, **a Li, ... Jun **ao in Supportive Care in Cancer
    Article 30 December 2023
  6. Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies

    Background

    Furmonertinib (AST2818) is a brain penetrant pan-epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) targeting both EGFR ...

    **ngsheng Hu, Shucai Zhang, ... Yuankai Shi in BMC Medicine
    Article Open access 28 April 2023
  7. Prevalence and quantity of lymph nodes at mediastinal stations in patients with lung cancer: lessons from 181 bilateral mediastinal lymphadenectomies

    Background

    This study evaluated the prevalence and quantity of lymph nodes at particular stations of the mediastinum in patients with lung cancer....

    Łukasz Trybalski, Jakub Szadurski, ... Piotr Kocoń in Journal of Cardiothoracic Surgery
    Article Open access 02 July 2024
  8. When chronic obstructive pulmonary disease meets small cell lung cancer: an unusual case report of rapid progression

    Background

    Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease and a risk factor for lung cancer. Small cell lung cancer is...

    Xu Zhang, Jia Zeng, ... Zhishu Li in BMC Geriatrics
    Article Open access 11 December 2023
  9. Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care

    Purpose

    Lung cancer is the leading cause of cancer deaths in Canada, and because early cancers are often asymptomatic screening aims to prevent...

    Jennifer Pillay, Sholeh Rahman, ... Lisa Hartling in Systematic Reviews
    Article Open access 16 March 2024
  10. Costs of traditional Chinese medicine treatment for inpatients with lung cancer in China: a national study

    Background

    Traditional Chinese Medicine (TCM) has long been a widely recognized medical approach and has been covered by China’s basic medical...

    Hanlin Nie, Zhaoran Han, ... Xuefeng Shi in BMC Complementary Medicine and Therapies
    Article Open access 09 January 2023
  11. FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer

    The focal adhesion kinase (FAK) tyrosine kinase is activated and upregulated in multiple cancer types including small cell lung cancer (SCLC)....

    **anteng Wang, **ngkai Li, ... Bing Wang in Oncogene
    Article 09 April 2024
  12. Dose–response relationship between active smoking and lung cancer mortality/prevalence in the Chinese population: a meta-analysis

    Background

    The dose‒response relationship-based relative risk (RR) of smoking exposure could better predict the risk of lung cancer than the...

    Feiling Ai, Jian Zhao, ... **a Wan in BMC Public Health
    Article Open access 24 April 2023
  13. The effect of incentive spirometry in perioperative patients with lung cancer—a systematic review and meta-analysis

    Background

    Incentive spirometry (IS) as a routine respiratory therapy during the perioperative period has been widely used in clinical practice....

    Yan Liang, Shaolin Chen, ... Xu Luo in BMC Pulmonary Medicine
    Article Open access 15 February 2024
  14. Anti-microbial and anti-cancer efficacy of acetone extract of Rosa chinensis against resistant strain and lung cancer cell line

    Background

    Screening of herbal plants for various therapeutic properties is the hour as it shows promising activity. Scientific evidence of the...

    Kalaivani Madhavaram Kuppusamy, Sivakumar Selvaraj, ... Krishnamoorthy Gunasekaran in BMC Complementary Medicine and Therapies
    Article Open access 10 November 2023
  15. Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer

    Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer characterized by rapid tumor growth and early metastasis. Accurate...

    Yibo Zhang, Zijian Yang, ... Meng Zhou in npj Digital Medicine
    Article Open access 18 January 2024
  16. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer

    Lung cancer is a disease in which lung cells grow abnormally and uncontrollably, and the cause of it is direct smoking, secondhand smoke, radon,...

    Abdulkarim S. Binshaya, Omar Saad Alkahtani, ... Hassan H. Almasoudi in Medical Oncology
    Article 28 March 2024
  17. Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer

    Purpose of Review

    With increased detection of early-stage non-small cell lung cancer (NSCLC) owing to screening, determining optimal management...

    Arthur Streit, Savvas Lampridis, ... Andrea Bille in Current Oncology Reports
    Article 22 December 2023
  18. LungCARE: Encouraging Shared Decision-Making in Lung Cancer Screening—a Randomized Trial

    Background

    Lung cancer screening (LCS) is recommended for individuals at high risk due to age and smoking history after a shared decision-making...

    Judith M. E. Walsh, Leah Karliner, ... Celia P. Kaplan in Journal of General Internal Medicine
    Article Open access 31 August 2023
  19. Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study

    Background

    Cyclin D1 ( CCND1 ) plays a pivotal role in cancer susceptibility and the platinum-based chemotherapy response. This study aims to assess...

    Chao Mei, Tian Wang, ... Wei**g Gong in BMC Pulmonary Medicine
    Article Open access 08 April 2024
  20. Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review

    Background

    Lung cancer is the leading cause of cancer-related mortality worldwide. Sarcopenia, defined as the loss of muscle mass and function, is...

    Ting-Yu Lin, Yen-Fu Chen, ... Levent Özçakar in Discover Oncology
    Article Open access 28 October 2022
Did you find what you were looking for? Share feedback.